Get the Stockscreener App
144.50
3.20%
4.48
After Hours:
144.50
Natera Inc stock is traded at $144.50, with a volume of 2.56M.
It is up +3.20% in the last 24 hours and down -15.96% over the past month.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
See More
Previous Close:
$140.02
Open:
$145.53
24h Volume:
2.56M
Relative Volume:
1.73
Market Cap:
$17.74B
Revenue:
$1.53B
Net Income/Loss:
$-214.69M
P/E Ratio:
-82.10
EPS:
-1.76
Net Cash Flow:
$-43.68M
1W Performance:
-2.31%
1M Performance:
-15.96%
6M Performance:
+15.49%
1Y Performance:
+59.12%
1-Day Range:
$143.35
$149.77
1-Week Range:
$127.75
$149.77
52-Week Range:
$83.13
$183.00
Natera Inc Stock (NTRA) Company Profile
Name
Natera Inc
Sector
Industry
Phone
650-249-9090
Address
13011 MCCALLEN PASS, AUSTIN, CA
Compare NTRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
144.50 | 17.74B | 1.53B | -214.69M | -43.68M | -1.76 |
|
TMO
Thermo Fisher Scientific Inc
|
512.65 | 193.40B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
204.96 | 146.49B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
119.85 | 34.19B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IDXX
Idexx Laboratories Inc
|
412.40 | 33.54B | 3.90B | 887.87M | 798.08M | 10.67 |
|
IQV
Iqvia Holdings Inc
|
185.42 | 32.69B | 15.41B | 1.37B | 2.11B | 7.50 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-23-25 | Initiated | Barclays | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Apr-08-24 | Resumed | Craig Hallum | Buy |
| Feb-20-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-29-23 | Reiterated | BTIG Research | Buy |
| Dec-14-23 | Initiated | Guggenheim | Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Nov-13-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| May-05-23 | Initiated | UBS | Buy |
| Jan-18-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Apr-25-22 | Initiated | Stephens | Overweight |
| Mar-08-22 | Initiated | Goldman | Buy |
| Jan-06-22 | Resumed | Piper Sandler | Overweight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-15-21 | Initiated | Raymond James | Mkt Perform |
| May-25-21 | Initiated | Wells Fargo | Overweight |
| Jan-28-21 | Initiated | Truist | Buy |
| Oct-08-20 | Initiated | BTIG Research | Buy |
| Sep-28-20 | Initiated | Morgan Stanley | Overweight |
| Sep-17-20 | Initiated | SVB Leerink | Outperform |
| Jun-10-20 | Resumed | Piper Sandler | Overweight |
| May-07-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-05-18 | Initiated | JP Morgan | Neutral |
| Jul-05-18 | Reiterated | Piper Jaffray | Overweight |
| Aug-07-17 | Reiterated | Morgan Stanley | Overweight |
| Nov-10-16 | Reiterated | The Benchmark Company | Buy |
| May-23-16 | Reiterated | The Benchmark Company | Buy |
| May-11-16 | Reiterated | The Benchmark Company | Buy |
| Apr-19-16 | Initiated | The Benchmark Company | Buy |
| Sep-28-15 | Upgrade | Wedbush | Neutral → Outperform |
| Aug-14-15 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-04-15 | Initiated | Robert W. Baird | Outperform |
| Jul-27-15 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-27-15 | Initiated | Piper Jaffray | Overweight |
| Jul-27-15 | Initiated | Wedbush | Neutral |
View All
Natera Inc Stock (NTRA) Latest News
Natera Appoints Monica Bertagnolli to Board of Directors - TipRanks
Natera initiated with an Outperform at RBC Capital - TipRanks
Minimal Residual Disease Market Expected to rise, 2032 | Adaptive Biotechnologies, Bristol-Myers Squibb Company, Natera, Kite Pharma, Amgen Inc., expected to boost the market - Barchart
Natera at Leerink’s Global Healthcare Conference: Strategic Growth Insights - Investing.com
Natera's Stock Rebounds Amid Market VolatilityNews and Statistics - IndexBox, Inc.
How Do Investors Really Feel About Natera? - Benzinga
Why Is Natera (NTRA) Stock Soaring Today - Yahoo Finance
Natera (NASDAQ:NTRA) Upgraded at StockNews.com - Defense World
Natera launches HEROES trial for breast cancer treatment - Investing.com India
Natera launches HEROES trial for breast cancer treatment By Investing.com - Investing.com South Africa
Natera enrolls first patients in HEROES clinical trial Metastatic HER2+ BC - TipRanks
Natera Begins Major Clinical Trial for Breast Cancer Therapy Management - StockTitan
Non-invasive Prenatal Testing (NIPT) Market Growth and Future - openPR
Natera damages blow; Ozempic patent gold rush; H&M IP strategy; Tesla loses Avanci 5G appeal; International Women’s Day; plus much more - IAM
Natera, Inc. (NASDAQ:NTRA) Stake Increased by Smartleaf Asset Management LLC - Defense World
Solomon Moshkevich Sells 6,000 Shares of Natera, Inc. (NASDAQ:NTRA) Stock - Defense World
Steven Leonard Chapman Sells 87,272 Shares of Natera, Inc. (NASDAQ:NTRA) Stock - Defense World
Natera, Inc. (NASDAQ:NTRA) Position Decreased by US Bancorp DE - Defense World
Natera, Inc. to Host Earnings Call - ACCESS Newswire
Natera president sells $859,734 in company stock By Investing.com - Investing.com Canada
Natera CEO Steven Chapman sells $12.5 million in stock - Investing.com
Natera Executives Conduct Significant Stock Sales - TradingView
Natera (NTRA) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance
Morgan Stanley Boosts Natera (NASDAQ:NTRA) Price Target to $185.00 - Defense World
Piper Sandler Forecasts Strong Price Appreciation for Natera (NASDAQ:NTRA) Stock - Defense World
Natera Set to Continue Upside Surprises During 2025, Beyond, Morgan Stanley Says - Marketscreener.com
Natera price target raised to $185 from $176 at Morgan Stanley - TipRanks
Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Natera, Inc. - ACCESS Newswire
Natera’s Strong Financial Performance and Growth Potential Reinforce Buy Rating - TipRanks
Private Advisor Group LLC Has $397,000 Stock Position in Natera, Inc. (NASDAQ:NTRA) - Defense World
Natera (NASDAQ:NTRA) Sees Large Volume Increase Following Analyst Upgrade - Defense World
USPTO issues Natera new patent related to testing of ctDNA - TipRanks
Natera Granted US Patent for Testing Single Nucleotide Variants -March 04, 2025 at 08:05 am EST - Marketscreener.com
How Natera's New Patent Could Reshape Cancer Detection Technology - StockTitan
Natera Full Year 2024 Earnings: Beats Expectations - Simply Wall St
Natera’s Strong Market Position and Growth Potential Justify Buy Rating - TipRanks
Research Analysts Issue Forecasts for Natera FY2027 Earnings - Defense World
Natera Inc. Earnings Call Highlights Strong Growth and Future Prospects - MSN
Natera Enters Oversold Territory (NTRA) - Nasdaq
Natera’s $96 million patent damages blow yet another written description/enablement upset - IAM
Natera (NASDAQ:NTRA) Price Target Raised to $188.00 - Defense World
Natera (NTRA) Reports Q4 Loss, Tops Revenue Estimates - MSN
Earnings Update: Natera, Inc. (NASDAQ:NTRA) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts - Yahoo Finance
Decoding Natera Inc (NTRA): A Strategic SWOT Insight - GuruFocus.com
Natera Inc (NTRA) Q4 2024 Earnings Call Highlights: Record Reven - GuruFocus.com
Bank of New York Mellon Corp Lowers Stock Holdings in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
(NTRA) Technical Data - Stock Traders Daily
Natera, Inc. (NASDAQ:NTRA) Q4 2024 Earnings Call Transcript - MSN
New York State Common Retirement Fund Sells 8,864 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera co-founder Sheena Jonathan sells $914,873 in stock - Investing.com India
Natera (NASDAQ:NTRA) Posts Quarterly Earnings Results, Beats Expectations By $0.01 EPS - MarketBeat
Natera Inc Stock (NTRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.03%
1.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):